Back to search

Molecular Medical Ltd

13222505

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Negative net worth (-10)

Details

2 GLENWOOD VILLAS FIFIELD LANE, FARNHAM, GU10 3AR
Incorporated 24/02/2021

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Dr Sean Leo Willis

director · Since 24/02/2021

MANAGING DIRECTOR

BRITISH · ENGLAND · Age 57

Also on 1 other board

Mr Pedro Garcia

director · Since 11/12/2022

DIRECTOR

BRITISH · ENGLAND · Age 58

Persons with Significant Control

Dr Sean Leo Willis

25–50% shares
25–50% votes
Appoint directors

British · England · Age 57

2 Glenwood Villas, Fifield Lane, Farnham, GU10 3AR

Notified 24/02/2021

Mr Pedro Garcia

25–50% shares
25–50% votes

British · England · Age 58

2 Glenwood Villas, Fifield Lane, Farnham, GU10 3AR

Notified 10/12/2022

CompanyRankvs 1397+ SIC 72110 peers
54

Financial strength9th percentile among SIC peers · 2/25
Employees77th percentile among SIC peers · 12/15
LiquidityCurrent ratio 10.63× · 20/20
Longevity5 years trading (max 15) · 5/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
1397Molecular Medical Ltd
54
How is this score calculated?
Financial strength2/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees12/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity5/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

-£117k

Balance sheet strength

Cash

£430k

Cash in the bank

Net Current Assets

£411k

Working capital

Current Assets

£454k

Current Liabilities

£43k

Fixed Assets

£69k

Debtors

£24k

3avg. employees

Balance Sheet

Assets less current liabilities£481k
Prepared with VT Final Accounts

EstimatesDerived

YearCurrent RatioImplied Profit
202410.63-£146k
202341.64+£25k
20220.93+£8k

Derived from filed accounts. Not audited figures.